Cellular reprogramming of adult somatic cells into induced pluripotent stem cells (iPSCs), their characterization as well as the optimization of reprogramming efficiency through novel methods for the future application of iPSCs in clinical regenerative me
Cellular reprogramming of adult somatic cells into induced pluripotent stem cells (iPSCs), their characterization as well as the optimization of reprogramming efficiency through novel methods for the future application of iPSCs in clinical regenerative me
批准号:
189892472
负责人:
Privatdozentin Dr. Antje Dagmar Ebert
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Fellowships
财政年份:
2010
资助国家:
德国
项目状态:
已结题
起止时间:
2009-12-31 至 2011-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Reprogramming of adult somatic cells into induced pluripotent stem cells (iPSCs) is a powerful approach that offers new options for regenerative medicine in the future. Because iPSCs are derived from the somatic tissues of recipient patients, they avoid two major concerns that embryonic stem cells (ESCs) are fraught with: Firstly, the ethical concern of destroying human embryos and oocytes and secondly, the immunological response and rejection of ESCs by the recipient patient. The goal of this project is the generation of iPSCs from adult human adipose stromal cells (hASCs) using non-viral methods. hASCs have been recently introduced as a resource of patient-specific differentiated donor cells for reprogramming into a pluripotent, undifferentiated status. In this project, hASC-derived iPSCs will be characterized using network pathway analysis and transcriptional profiling. Moreover, microRNAs will be employed as a novel tool to control self-renewal and differentiation and hence to increase reprogramming efficiency. Thus this project aims at improving the efficiency of iPSCs generation through new strategies and to understand the fate and functionality of iPSC derivatives. This should contribute to both a better understanding of basic stem cell biology and to facilitating medical applications of stem cell research for clinical disease therapy in the future. This project will be performed in the laboratory of Prof. Joseph Wu (MD, PhD), who has great expertise in the field of stem cell research as demonstrated by his extensive record of peer-reviewed publications and his numerous connections to internationally recognized experts in stem cell research, cellular reprogramming and micoRNAs. The valuable experience obtained during this postdoctoral research sojourn abroad in the laboratory of Prof. Joseph Wu will prepare and enable me to continue in the future as an established scientist in academic research in Germany.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
多囊卵巢综合征中甲酰肽受体2调控小胶质细胞代谢重编程导致GnRH神经元过度激活及HPO轴异常的病理机制研究
-
批准号:82370797
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陶弢
-
依托单位:
基于AMPK/PGC-1α信号轴的工程化外泌体靶向调控BMSCs能量代谢重编程在老年机体骨修复中的作用及其机制研究
-
批准号:82370920
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:周名亮
-
依托单位:
Hippo信号通路调控胃粘膜损伤修复的细胞与分子机制
-
批准号:92168116
-
项目类别:重大研究计划
-
资助金额:80.0万元
-
批准年份:2021
-
负责人:焦石
-
依托单位:
小鼠肺腺鳞癌转分化类器官模型的建立及表观调控分子机制研究
-
批准号:32100593
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:童欣媛
-
依托单位:
KLF5诱导小鼠始发态多能性干细胞向滋养层干细胞转变的作用与机制研究
-
批准号:32100596
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:黄颖华
-
依托单位:
调控拟南芥体细胞再生关键基因的鉴定
-
批准号:32000507
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:杜斐
-
依托单位:
中性粒细胞在体内条件下重编程为造血干祖细胞的研究
-
批准号:92068101
-
项目类别:重大研究计划
-
资助金额:80.0万元
-
批准年份:2020
-
负责人:程林
-
依托单位:
细胞衰老抑制直接重编程及心肌再生修复的分子机理研究
-
批准号:92068107
-
项目类别:重大研究计划
-
资助金额:79.0万元
-
批准年份:2020
-
负责人:王丽
-
依托单位:
m6A识别蛋白YTHDFs在体细胞重编程中的调控作用及机制研究
-
批准号:32000501
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:杨雪洁
-
依托单位:
转录因子SALL4通过影响pre-mRNA可变剪接调控非Yamanaka因子体细胞重编程的机制研究
-
批准号:32000502
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:王波
-
依托单位: